- Home
- ORIO vs ABVC Comparison
ORIO vs ABVC Comparison
Compare ORIO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIO | ABVC |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 26.1M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ORIO | ABVC |
|---|---|---|
| Price | $0.92 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 71.6K |
| Earning Date | 11-06-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | $64.78 | N/A |
| Revenue Next Year | $7.46 | $171.50 |
| P/E Ratio | $4.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $0.71 |
| 52 Week High | $1.40 | $3.06 |
Technical Indicators
Market Signals| Indicator | ORIO | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 43.31 |
| Support Level | $0.90 | $0.92 |
| Resistance Level | $0.98 | $1.14 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 34.36 | 25.63 |
Price Performance
Historical ComparisonAbout ORIO Orion Digital Corp. Common Shares
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.